161 related articles for article (PubMed ID: 20418720)
1. Testosterone and type 2 diabetes.
Grossmann M; Gianatti EJ; Zajac JD
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):247-56. PubMed ID: 20418720
[TBL] [Abstract][Full Text] [Related]
2. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
3. Androgens, insulin resistance and vascular disease in men.
Kapoor D; Malkin CJ; Channer KS; Jones TH
Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808
[TBL] [Abstract][Full Text] [Related]
4. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
Niskanen L; Laaksonen DE; Punnonen K; Mustajoki P; Kaukua J; Rissanen A
Diabetes Obes Metab; 2004 May; 6(3):208-15. PubMed ID: 15056129
[TBL] [Abstract][Full Text] [Related]
5. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
Kapoor D; Clarke S; Channer KS; Jones TH
Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
[TBL] [Abstract][Full Text] [Related]
7. Androgens and obesity.
Allan CA; McLachlan RI
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):224-32. PubMed ID: 20418719
[TBL] [Abstract][Full Text] [Related]
8. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
Traish AM; Saad F; Guay A
J Androl; 2009; 30(1):23-32. PubMed ID: 18772488
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadotrophic hypogonadism in type 2 diabetes.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and the metabolic syndrome.
Johannsson G; Bengtsson BA
J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadism and diabetes.
Betancourt-Albrecht M; Cunningham GR
Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
[TBL] [Abstract][Full Text] [Related]
12. Does low testosterone affect adaptive properties of adipose tissue in obese men?
Ruige JB
Arch Physiol Biochem; 2011 Feb; 117(1):18-22. PubMed ID: 21073297
[TBL] [Abstract][Full Text] [Related]
13. Obesity and testicular function.
Mah PM; Wittert GA
Mol Cell Endocrinol; 2010 Mar; 316(2):180-6. PubMed ID: 19540307
[TBL] [Abstract][Full Text] [Related]
14. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.
Bojesen A; Høst C; Gravholt CH
Mol Hum Reprod; 2010 Jun; 16(6):396-401. PubMed ID: 20231162
[TBL] [Abstract][Full Text] [Related]
15. Testosterone deficiency and the metabolic syndrome.
Lunenfeld B
Aging Male; 2007 Jun; 10(2):53-6. PubMed ID: 17558968
[TBL] [Abstract][Full Text] [Related]
16. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection.
Cohen PG
Med Hypotheses; 2001 Jun; 56(6):702-8. PubMed ID: 11399122
[TBL] [Abstract][Full Text] [Related]
17. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
[TBL] [Abstract][Full Text] [Related]
18. Effective treatments for insulin resistance: trim the fat and douse the fire.
Evans JL; Youngren JF; Goldfine ID
Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.
Corona G; Mannucci E; Forti G; Maggi M
Int J Androl; 2009 Dec; 32(6):587-98. PubMed ID: 19226407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
